FLCN and kidney cancer: According to the revised Chinese BHD criteria, 95 lung lesions (99%), 5 kidney cancers (6.4%), and 5 (5.8%) skin lesions met the clinical diagnostic criteria, 85 (98.8%) pathogenic FLCN mutations met the genetic diagnostic criteria, and 35 (35%) had first-degree relatives with confirmed diagnosis.